EliteCell
EliteCell manufactures cGMP-compliant human platelet lysate (hPL) cell culture supplements and lymphocyte media for cell therapy developers, CDMOs, and academic researchers, distributing globally across the USA and Asia-Pacific.
- Company typePrivate
- Founded2012
- HeadquartersWoodway, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What EliteCell does
Biomedical EliteCell Corp. (operating as EliteCell) manufactures and sells cell culture supplements and media used by cell therapy developers, contract development and manufacturing organizations (CDMOs), and academic research organizations. The company is headquartered in Woodway, Texas, where it operates a cGMP-compliant production facility registered under FDA 21 CFR Part 820. Its product portfolio centers on human platelet lysate (hPL) cell culture supplements offered in research-use (RUO) and GMP-grade formats — including the EliteGro family (EliteGro, EliteGro-Adv., and the gamma-irradiated EliteGro-Adv.-GI) and the immune-cell-optimized EliteMu — together with chemically defined, xenogeneic-free lymphocyte media (EL837) and an NK cell induction and expansion kit. All hPL products are manufactured from 100% human-derived raw materials sourced exclusively from FDA-licensed and AABB-accredited U.S. blood centers.
The company's underlying technology rests on a proprietary fibrinogen-depletion process that removes the need for heparin and preserves a fully xenogeneic-free status, paired with a separately validated gamma irradiation process compliant with ICH Q5A guidelines that inactivates human pathogens including B19 parvovirus. EliteCell has filed an FDA Drug Master File (DMF No. 032759) and a CBER Master File (MF# 27525) covering its GMP-grade hPL products, which cell therapy customers can cross-reference in their own regulatory submissions.
EliteCell commercializes through a hybrid motion: regional distributor partnerships covering Asia-Pacific markets (China via Dakewe Biotech on an exclusive basis, plus Thailand, Taiwan, India, South Korea, Malaysia, Singapore, and Japan) and direct enterprise engagement managed through a website quotation and technical-support channel. Pricing is quote-based and varies by product grade (RUO vs. GMP), volume, and customer requirements, with indications of multi-year contracts. Marketing emphasizes scientific credibility — a peer-reviewed publication record in Nature, Nature Immunology, Journal of Experimental Medicine, and Stem Cell Research & Therapy — and active exhibition presence at ISSCR Hong Kong 2025, BIO Asia-Taiwan 2025, BIO AP International Thailand 2025, and Healthcare+ Expo Taiwan.
EliteCell firmographics
Firmographics- Name
- EliteCell
- Legal name
- Biomedical EliteCell Corp.
- Website
- https://elitecellbio.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- EliteCell manufactures cGMP-compliant human platelet lysate (hPL) cell culture supplements and lymphocyte media for cell therapy developers, CDMOs, and academic researchers, distributing globally across the USA and Asia-Pacific.
- Ownership category
- akta.pro rank
EliteCell industry classification
Industry- Product category
- Cell Culture Supplements
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH)
- akta.pro secondary industries
- Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability) (HLAAABAK), Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC)
Keywords
Where EliteCell is headquartered
LocationHeadquarters
- HQ city
- Woodway
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
EliteCell business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Human Platelet Lysate Products: Sale of cGMP and RUO-grade human platelet lysate supplements (EliteGro, EliteGro-Adv., EliteMu) in various sizes (50ml, 100ml, 500ml). Products available in research-use and GMP-grade formats for different customer requirements.
- Cell Culture Media and Kits: Sale of specialized cell culture media (EL837 Serum-Free Medium) and NK Induction and Expansion Kits for lymphocyte expansion applications. Available in both research and GMP grades.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for all products |
Go-to-market motion2 records
Distribution channels10 records
Marketing channels5 records
EliteCell product offering
Product offeringCore offering
EliteCell manufactures and sells human platelet lysate (hPL) cell culture supplements and lymphocyte culture media/kits used as animal-serum-free, xenogeneic-free raw materials in cell therapy and regenerative medicine manufacturing. The product portfolio spans RUO and cGMP-grade hPL (EliteGro, EliteGro-Adv., EliteMu), gamma-irradiated pathogen-inactivated variants, the EL837 chemically-defined serum-free medium, and an NK Induction and Expansion Kit, all sourced from FDA-licensed and AABB-accredited U.S. blood centers.
Product overview
EliteCell provides a comprehensive portfolio of human platelet lysate (hPL) cell culture supplements and lymphocyte culture media for cell therapy and regenerative medicine applications. The product line centers on validated human platelet lysate solutions (EliteGro™, EliteGro™-Adv., EliteMu™) available in research-use (RUO) and cGMP-grade formats, supplemented by specialized lymphocyte culture products (EL837 Serum-Free Medium, NK Induction and Expansion Kit). The fibrinogen-depleted formulations (EliteGro™-Adv.) eliminate the need for heparin, while gamma-irradiated variants (GI) offer additional pathogen safety. Products range from RUO-grade supplements for research through clinical-grade materials (CBER MF# 27525) for commercial cell therapy manufacturing, all sourced exclusively from FDA-licensed and AABB-accredited U.S. blood centers.
Differentiator
Problem solved
Functional benefit
Brands
- EliteGro™: Xenogeneic-free human platelet lysate (hPL) product line available in RUO Grade formats (EliteGro EPG), supports cell expansion for MSC and immune cells
- EliteGro™-Adv.
- EliteGro™-Adv.-GI (Gamma Irradiated)
- EliteMu™
- EL837 Serum-Free Medium
- EliteCell NK Kit
Products and services
- EliteGro (RUO Grade hPL)
Quantifiable outcome
- Replace 10% FBS with only 5% EliteGro or EliteGro-Adv. for better cell growth
- +5 more outcomes
Companies that use EliteCell
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
EliteCell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
EliteCell partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- Dakewe Biotech Company LimitedcoreExclusive distributor for China market. Headquarters located in Nanshan District, Shenzhen, Guangdong 518054, China. Contact: +86-755-2640-5921, http://www.dakewe.com
- A.N.H. Scientific Marketing Co., Ltd.coreDistributor for Thailand market. Located in Lak Si, Bangkok 10210, Thailand. Contact: +66-84-636-9921, [email protected]
- NK BiotechnologycoreDistributor for Taiwan market. Located in Tucheng District, New Taipei City 23643, Taiwan. Contact: +886-2-2266-4162, [email protected]
- Celltech Biosciences LLPcoreDistributor for India market. Located in New Delhi-110066, India. Contact: +91-92890-79850, [email protected]
- SOOMBIOcoreDistributor for South Korea market. Located in Hanam-Si, Gyeonggi-Do 12918, Republic of Korea. Contact: +82-0-31-608-1024, [email protected]
- Next Gene Scientific Sdn. Bhd.coreDistributor for Malaysia market. Located in Petaling Jaya, 47100 Selangor, Malaysia. Contact: +60-3-8051-5106, [email protected]
- Essen-Haus (Bioscience) Sdn. Bhd.coreDistributor for Malaysia market. Located in Subang Jaya, 47500 Selangor, Malaysia. Contact: +60-3-5631-0273, [email protected]
- Chemopharm Sdn. Bhd. (Everlife Group)coreDistributor for Malaysia market under Everlife Group. Located in Petaling Jaya, 47300 Selangor, Malaysia. Contact: +60-3-7872-6000, [email protected]
- Research Instruments Pte. Ltd. (Everlife Group)coreDistributor for Singapore market under Everlife Group. Located at 1 Clementi Loop, #06-01, Singapore 129808. Contact: +65-6571-0888, [email protected]
- FDA-Licensed and AABB-Accredited U.S. Blood CenterscoreStrategic raw material supply partnership ensuring 100% traceability of human-derived raw materials. All platelet units sourced exclusively from FDA-registered and AABB-accredited blood banks in the USA. Critical for regulatory compliance and product safety profile.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
EliteCell competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: Lonza is the largest contract manufacturer and supplier of cell culture media and ancillary materials for cell therapy, including media products used in MSC and immune cell expansion. Broad incumbent with materially larger scale, broader portfolio, and global sales coverage that competes with EliteCell on larger commercial opportunities.
- Cytiva (Danaher): Cytiva supplies cell culture media and supplements for cell therapy and regenerative medicine, including products used in MSC and immune cell manufacturing. Broad incumbent with global commercial reach and a wide bioprocessing portfolio that overlaps EliteCell's product category at the larger-customer end of the market.
- Sartorius AG: Sartorius provides cell culture media and bioprocess solutions for cell and gene therapy manufacturing. Broad incumbent with strong position in upstream bioprocessing where EliteCell's GMP-grade hPL is also sold into commercial and clinical cell therapy programs.
- STEMCELL Technologies: STEMCELL Technologies is a leading specialty life sciences tools provider offering cell culture media, supplements, and reagents for cell therapy and regenerative medicine research. Significantly broader portfolio and global commercial reach make it a broad incumbent competitor to EliteCell's niche hPL and lymphocyte media offering.
- Corning Life Sciences: Corning Life Sciences supplies cell culture media, sera, and supplements (including xeno-free formulations) for research and cell therapy applications. Broad incumbent with established distribution into academic and biotech customers that overlaps EliteCell's target segments.
- Thermo Fisher Scientific: Thermo Fisher supplies cell culture media, supplements, and ancillary products (including Gibco brand) used across cell therapy manufacturing. As the largest life sciences tools company, it competes with EliteCell on commercial-scale cell therapy opportunities and CDMO accounts.
Direct peers
- Macopharma: Macopharma is an established manufacturer of blood-derived products and human platelet lysate for cell therapy applications. Direct competitor in the cGMP hPL category with broader blood banking heritage and European manufacturing footprint.
- Mill Creek Life Sciences: Mill Creek Life Sciences manufactures human platelet lysate (hPL) products (UltraGRO and ABCyte) for cell therapy manufacturing. Direct product overlap with EliteCell's EliteGro line and shared target customer base of cell therapy developers and CDMOs.
- Compass Biomedical: Compass Biomedical is a direct competitor in human platelet lysate (hPL) cell culture supplements for cell therapy manufacturing. Overlapping product portfolio (hPL alternatives to FBS) and similar customer base of cell therapy developers, CDMOs, and academic research customers.
- PL BioScience: PL BioScience is a European manufacturer of human platelet lysate (hPL) cell culture supplements for cell therapy and regenerative medicine. Direct competing offering to EliteGro/EliteGro-Adv. targeting similar GMP and RUO-grade customer segments in MSC and immune cell expansion.
Market position
Strengths3 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
EliteCell social profiles
Digital presenceEliteCell financial estimates
Financial estimateRevenue estimate
Valuation estimate
EliteCell leadership team
Management profileNumber of profiles
EliteCell funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EliteCell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EliteCell
What does EliteCell do?
EliteCell manufactures and sells human platelet lysate (hPL) cell culture supplements and lymphocyte culture media/kits used as animal-serum-free, xenogeneic-free raw materials in cell therapy and regenerative medicine manufacturing. The product portfolio spans RUO and cGMP-grade hPL (EliteGro, EliteGro-Adv., EliteMu), gamma-irradiated pathogen-inactivated variants, the EL837 chemically-defined serum-free medium, and an NK Induction and Expansion Kit, all sourced from FDA-licensed and AABB-accredited U.S. blood centers.
Is EliteCell a public or private company?
EliteCell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EliteCell founded?
EliteCell was founded in 2012. It employs 51 to 100 people.
Where is EliteCell based?
EliteCell is headquartered in Woodway, United States, in the North America region.
How does EliteCell make money?
Two revenue lines are on record. Human Platelet Lysate Products are the primary driver. The others are cell Culture Media and Kits.
Who are EliteCell's main competitors?
Broad incumbents on record are Lonza Group, Cytiva (Danaher), Sartorius AG, STEMCELL Technologies, Corning Life Sciences and Thermo Fisher Scientific. Direct peers are Macopharma, Mill Creek Life Sciences, Compass Biomedical and PL BioScience.
Does EliteCell have an API?
No public API is recorded for EliteCell.
What industry is EliteCell in?
EliteCell's product category is Cell Culture Supplements. Its primary akta.pro industry code is HLAAABAH, Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables), with a secondary code of HLAAABAK, Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability). Its NAICS code is 325414 and its SIC code is 2836.